Clinical Trial Update: Prospective Evaluation of a Commercially Available Hydrogel Spacer

View source ↗

Summary

Sponsored by BioProtect, this prospective evaluation of a commercially available hydrogel spacer for prostate cancer radiotherapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: BioProtect | Conditions: Prostate Cancer | Status: COMPLETED